Literature DB >> 19414390

Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.

S Katsimpoula1, M Patrinou-Georgoula, N Makrilia, K Dimakou, A Guialis, D Orfanidou, K N Syrigos.   

Abstract

BACKGROUND: Overexpression of heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 has recently been suggested to be a promising marker for early detection of lung cancer. The aim of this study was to determine the utility of its detection in bronchoscopic specimens. PATIENTS AND METHODS: Brushing and biopsy specimens were obtained from 61 patients suspected of having lung cancer, as well as from 30 healthy subjects (controls), who underwent bronchoscopy. hnRNPA2/B1 expression levels were evaluated by immunoblotting.
RESULTS: Specificity of hnRNP A2/B1 overexpression was 75.9% in brushing and 78.3% in biopsy. Sensitivity in non-small cell lung cancer was 84.8% in brushing and 80.8% in biopsies, while in small cell lung cancer it was 66.7 % and 75%, respectively. Overexpression of hnRNPA2/B1 was also detected in bronchoscopic specimens of nine patients initially undiagnosed. The follow-up of these patients 2 years later showed that seven of them had developed lung cancer.
CONCLUSION: Overexpression of hnRNPA2/B1 was significantly higher in patients suffering from lung cancer and may be useful in the early detection of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414390

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.

Authors:  Xiao-Han Qu; Jin-Lu Liu; Xin-Wen Zhong; X I Li; Qi-Gang Zhang
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

2.  Elevated copper remodels hepatic RNA processing machinery in the mouse model of Wilson's disease.

Authors:  Jason L Burkhead; Martina Ralle; Phillip Wilmarth; Larry David; Svetlana Lutsenko
Journal:  J Mol Biol       Date:  2010-12-10       Impact factor: 5.469

3.  hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers.

Authors:  Yang Xuan; Jingshu Wang; Liying Ban; Jian-Jun Lu; Canhui Yi; Zhenglin Li; Wendan Yu; Mei Li; Tingting Xu; Wenjing Yang; Zhipeng Tang; Ranran Tang; Xiangsheng Xiao; Songshu Meng; Yiming Chen; Quentin Liu; Wenlin Huang; Wei Guo; Xiaonan Cui; Wuguo Deng
Journal:  Mol Oncol       Date:  2015-11-30       Impact factor: 6.603

4.  Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters.

Authors:  Meenakshi Sudhakaran; Michael Ramirez Parra; Hayden Stoub; Kathleen A Gallo; Andrea I Doseff
Journal:  Biochem Pharmacol       Date:  2020-10-02       Impact factor: 5.858

5.  Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.

Authors:  Georgios Boukakis; Meropi Patrinou-Georgoula; Maria Lekarakou; Christos Valavanis; Apostolia Guialis
Journal:  BMC Cancer       Date:  2010-08-17       Impact factor: 4.430

6.  Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.

Authors:  Chi-Yuan Chen; Chia-Ing Jan; Wen-Chieh Pi; Wen-Lung Wang; Pan-Chyr Yang; Tong-Hong Wang; Rotem Karni; Tzu-Chien V Wang
Journal:  Oncotarget       Date:  2016-03-29

7.  Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression.

Authors:  Chia-Yang Hung; Yi-Chang Wang; Jian-Ying Chuang; Ming-Jer Young; Hungjiun Liaw; Wen-Chang Chang; Jan-Jong Hung
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

8.  Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.

Authors:  Xiang Shi; Li Ran; Yao Liu; Shu-Huai Zhong; Ping-Ping Zhou; Ming-Xin Liao; Wen Fang
Journal:  Oncol Rep       Date:  2018-01-05       Impact factor: 3.906

9.  Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis.

Authors:  Oliver H Voss; Daniel Arango; Justin C Tossey; Miguel A Villalona Calero; Andrea I Doseff
Journal:  Cell Death Dis       Date:  2021-03-17       Impact factor: 8.469

10.  Quantitative proteome analysis of Merkel cell carcinoma cell lines using SILAC.

Authors:  Ulana Kotowski; Boban M Erović; Julia Schnöll; Victoria Stanek; Stefan Janik; Martin Steurer; Goran Mitulović
Journal:  Clin Proteomics       Date:  2019-12-19       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.